ACT_589997/2023

System for ambulatory drug infusion comprising a filling apparatus for flexible containers

RevocationMain Revocation ActionParis CDRevocation Action—

Overview Decisions Reasoning Documents Timeline

Parties

Claimants

Tandem Diabetes Care, Inc.
Tandem Diabetes Care Europe B.V.

Reps: Charlotte Garnitsch (Taylor Wessing N.V.); Wim Maas (Taylor Wessing N.V.); Alexander Rubusch (Taylor Wessing); George Seezink (AOMB)

Respondents

Roche Diabetes Care GmbH(Roche Group)

Reps: Christof Augenstein (Kather Augenstein); Katharina Brandt (Kather Augenstein); Thomas Kronberger (Grünecker Patent- und Rechtsanwälte)

Judges

French-seated division — individual judges anonymized.

Panel member (anonymized)Presiding Judge and Judge-Rapporteur
Panel member (anonymized)Legally Qualified Judge
Panel member (anonymized)Technically Qualified Judge

Patents

EP2196231

CPC codes: A61M2209/045, A61M5/148, A61M5/14244

Technology area: Medical Devices · Drug Delivery

Sector: Pharmaceutical & Medical

Outcome

Patent maintainedMaintained as granted

Filed: —

First decided: Dec 18, 2024

Language: —

The Paris Central Division dismissed Tandem Diabetes Care's revocation action against Roche's EP 2 196 231 B1 (ambulatory drug infusion system), maintaining the patent as granted and ordering the claimants to bear the costs of proceedings, finding the grounds for invalidity (including lack of inventive step over prior art Diaz/Robertson/Glejboel) were not proven.

Claims

At issueall

Maintainedall

Notes: Paris Central Division dismissed revocation action against EP2196231 in its entirety; patent maintained as granted with no specific claim-by-claim breakdown in excerpts.